Piroxicam inhibits herpes simplex virus type 1 infection in vitro
Piroxicam is a potent, nonsteroidal, anti-inflammatory agent (NSAID) which also exhibits antipyretic activity. The antiviral effect of piroxicam against herpes simplex virus type 1 (HSV-1) was examined in vitro on RC-37 monkey kidney cells using a plaque reduction assay. Piroxicam - was dissolved in...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
1. Mai 2015
|
| In: |
Die Pharmazie
Year: 2015, Jahrgang: 70, Heft: 5, Pages: 331-336 |
| ISSN: | 3053-691X |
| DOI: | 10.1691/ph.2015.4791 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1691/ph.2015.4791 Verlag, Volltext: https://www.ingentaconnect.com/content/govi/pharmaz/2015/00000070/00000005/art00011?crawler=true 
|
| Verfasserangaben: | A. Astani, U. Albrecht, P. Schnitzler |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1725650266 | ||
| 003 | DE-627 | ||
| 005 | 20230426183826.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200728s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1691/ph.2015.4791 |2 doi | |
| 035 | |a (DE-627)1725650266 | ||
| 035 | |a (DE-599)KXP1725650266 | ||
| 035 | |a (OCoLC)1341348628 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Astani, Akram |d 1974- |e VerfasserIn |0 (DE-588)143504363 |0 (DE-627)646581422 |0 (DE-576)337421803 |4 aut | |
| 245 | 1 | 0 | |a Piroxicam inhibits herpes simplex virus type 1 infection in vitro |c A. Astani, U. Albrecht, P. Schnitzler |
| 264 | 1 | |c 1. Mai 2015 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 28.07.2020 | ||
| 520 | |a Piroxicam is a potent, nonsteroidal, anti-inflammatory agent (NSAID) which also exhibits antipyretic activity. The antiviral effect of piroxicam against herpes simplex virus type 1 (HSV-1) was examined in vitro on RC-37 monkey kidney cells using a plaque reduction assay. Piroxicam - was dissolved in ethanol or dimethylsulfoxide (DMSO) and the 50% inhibitory concentration (IC50) was determined at 4 μg/ml and 75 μg/ml, respectively. The IC50 for the standard antiherpetic drug acyclovir was determined at 1.6 μM. At non-cytotoxic concentrations - of these piroxicam solutions, plaque formation was significantly reduced by 62.4% for ethanolic piroxicam and 72.8% for piroxicam in DMSO. The mode of antiviral action of these drugs was assessed by time-on-addition assays. No antiviral effect was observed when cells were incubated with piroxicam - prior to infection with HSV-1 or when HSV-1 infected cells were treated with dissolved piroxicam. Herpesvirus infection was, however, significantly inhibited when HSV-1 was incubated with piroxicam prior to the infection of cells. These results indicate that piroxicam affected the virus before - adsorption, but not after penetration into the host cell, suggesting that piroxicam exerts a direct antiviral effect on HSV-1. Free herpesvirus was sensitive to piroxicam in a concentration-dependent manner and the inhibition of HSV-1 appears to occur before entering the cell but not after - penetration of the virus into the cell. Considering the lipophilic nature of piroxicam, which enables it to penetrate the skin, it might be suitable for topical treatment of herpetic infections. | ||
| 700 | 1 | |a Albrecht, U. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schnitzler, Paul |d 1959- |e VerfasserIn |0 (DE-588)1022905643 |0 (DE-627)717329798 |0 (DE-576)366155695 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Die Pharmazie |d Eschborn : Avoxa, Mediengruppe Deutscher Apotheker, 1995 |g 70(2015), 5, Seite 331-336 |h Online-Ressource |w (DE-627)32445368X |w (DE-600)2026715-0 |w (DE-576)110736133 |x 3053-691X |7 nnas |a Piroxicam inhibits herpes simplex virus type 1 infection in vitro |
| 773 | 1 | 8 | |g volume:70 |g year:2015 |g number:5 |g pages:331-336 |g extent:6 |a Piroxicam inhibits herpes simplex virus type 1 infection in vitro |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1691/ph.2015.4791 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://www.ingentaconnect.com/content/govi/pharmaz/2015/00000070/00000005/art00011?crawler=true |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200728 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 1022905643 |a Schnitzler, Paul |m 1022905643:Schnitzler, Paul |d 910000 |d 911700 |e 910000PS1022905643 |e 911700PS1022905643 |k 0/910000/ |k 1/910000/911700/ |p 3 |y j | ||
| 998 | |g 143504363 |a Astani, Akram |m 143504363:Astani, Akram |p 1 |x j | ||
| 999 | |a KXP-PPN1725650266 |e 3730904434 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["A. Astani, U. Albrecht, P. Schnitzler"]},"recId":"1725650266","id":{"doi":["10.1691/ph.2015.4791"],"eki":["1725650266"]},"title":[{"title_sort":"Piroxicam inhibits herpes simplex virus type 1 infection in vitro","title":"Piroxicam inhibits herpes simplex virus type 1 infection in vitro"}],"person":[{"given":"Akram","roleDisplay":"VerfasserIn","display":"Astani, Akram","family":"Astani","role":"aut"},{"family":"Albrecht","given":"U.","roleDisplay":"VerfasserIn","display":"Albrecht, U.","role":"aut"},{"role":"aut","family":"Schnitzler","given":"Paul","roleDisplay":"VerfasserIn","display":"Schnitzler, Paul"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"1. Mai 2015","dateIssuedKey":"2015"}],"language":["eng"],"note":["Gesehen am 28.07.2020"],"physDesc":[{"extent":"6 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"note":["Frühere Jahrgänge online nicht mehr verfügbar","Fortsetzung der Druck-Ausgabe","Gesehen am 13.05.2020"],"language":["eng"],"disp":"Piroxicam inhibits herpes simplex virus type 1 infection in vitroDie Pharmazie","origin":[{"dateIssuedKey":"1995","publisherPlace":"Eschborn ; Eschborn ; [Erscheinungsort nicht ermittelbar]","dateIssuedDisp":"1995-","publisher":"Avoxa, Mediengruppe Deutscher Apotheker ; Govi-Verl. ; Swets"}],"part":{"volume":"70","text":"70(2015), 5, Seite 331-336","extent":"6","year":"2015","pages":"331-336","issue":"5"},"type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"Die Pharmazie <Eschborn>"}],"title":[{"title":"Die Pharmazie","subtitle":"an international journal of pharmaceutical sciences","title_sort":"Pharmazie"}],"recId":"32445368X","id":{"issn":["3053-691X"],"eki":["32445368X"],"zdb":["2026715-0"]},"pubHistory":["Nachgewiesen 50.1995 -"]}]} | ||
| SRT | |a ASTANIAKRAPIROXICAMI1201 | ||